Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Memotherm ºÎ¸ñÀ» ÀÌ¿ëÇÑ Àü¸³¼±ºñ´ëÁõÀÇ Ä¡·á Treatment of BPH with a Memotherm Urethral Stent

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 5È£ p.501 ~ 505
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤µµ¸° Àå¼®Èç/ÃÖÇзæ/½ÉºÀ¼®/¹Ú¿µ¿ä/±Ç¼º¿ø

Abstract


We describe the use of a new urethral stent implanted in 6 with prostatic outflow obstruction. All patients were in a high risk group for surgery and treated successfully, for a follow-up of 6 to 13 (mean 8.5) months.
The majority of patients were satisfied with the procedure, which provided a quick, safe and effective results, compared with conventional surgical treatment.
The stent, woven from nitinol in the form of a tubular mesh was inserted into the prostatic urethra via a delivery device using endoscopic control under local anesthesia. During follow-up period, the stent remained in situ and there were no
urinary
incontinence or other complications. The average maximum flow rate at postoperative 6 months was 19.5 ml/sec. This stent is a useful alternative to conventional surgical treatment in the high risk and large prostate gatient.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS